Internal Medicine, Rheumatology · Gillette, WY
NPI
1528385598
Since 2010
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
469 Highway 50
Gillette, WY, 82718
Phone (307) 387-9850
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.7M
180,753 services
Medicare patients, 2024
426
Average age 72
Drug cost, 2024
$3.3M
2,517 prescriptions
Company payments, 2025
$95K
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Horng-Chyi R Lai was code J3262 (injection, tocilizumab, 1 mg), 63,320 times for 22 patients. In total Horng-Chyi R Lai billed 180,753 services in 62 codes, and Medicare paid $3.7M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3262 Injection, tocilizumab, 1 mg | Office | 63,320 | 22 | $4.67 | $296K |
| J1306 Injection, inclisiran, 1 mg | Office | 13,633 | 32 | $9.47 | $129K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 12,460 | 53 | $24.88 | $310K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 10,100 | 15 | $8.98 | $91K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 7,125 | 13 | $33.96 | $242K |
| J9312 Injection, rituximab, 10 mg | Office | 3,501 | 22 | $59.41 | $208K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 1,943 | 39 | $0.22 | $435 |
| J0897 Injection, denosumab, 1 mg | Office | 1,920 | 27 | $21.08 | $40K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,041 | 20 | $0.10 | $108 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 546 | 223 | $12.19 | $6,653 |
| 99214 Office E&M - Established | Office | 525 | 230 | $88.53 | $46K |
| 96413 Chemotherapy Administration | Office | 511 | 145 | $100.11 | $51K |
| 96415 Chemotherapy Administration | Office | 375 | 81 | $21.29 | $7,982 |
| 96365 Intravenous Infusion, Hydration | Office | 274 | 58 | $48.94 | $13K |
| 36415 Venipuncture Blood Collection | Office | 263 | 112 | $8.62 | $2,266 |
By year: 2022 $2.3M for 145,482 services; 2023 $3.3M for 159,497 services; 2024 $3.7M for 180,753 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 263 | 112 | $8.62 | $2,266 |
Medicare prescription drug claims, 2024
In 2024, the drug Horng-Chyi R Lai prescribed most often to Medicare patients was Prednisone, with 437 prescriptions and refills. In total Horng-Chyi R Lai wrote 2,517 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 437 | 644 | 153 | $3,977 |
| Tramadol Hcl Generic | 271 | 282 | 67 | $2,016 |
| Hydroxychloroquine Sulfate Generic | 213 | 524 | 63 | $8,640 |
| Methotrexate Methotrexate Sodium | 185 | 368 | 50 | $4,956 |
| Celecoxib Generic | 157 | 282 | 41 | $5,564 |
| Leflunomide Generic | 136 | 298 | 40 | $8,751 |
| Pregabalin Generic | 128 | 136 | 23 | $2,349 |
| Cyclobenzaprine Hcl Generic | 118 | 181 | 31 | $886 |
| Kevzara Sarilumab | 103 | 104 | 17 | $441K |
| Allopurinol Generic | 67 | 191 | 15 | $922 |
| Enbrel Sureclick Etanercept | 44 | 51 | Under 11 | $377K |
| Tizanidine Hcl Generic | 38 | 48 | 13 | $517 |
| Rinvoq Upadacitinib | 36 | 42 | Under 11 | $269K |
| Humira(Cf) Pen Adalimumab | 35 | 35 | Under 11 | $237K |
| Duloxetine Hcl Generic | 34 | 58 | Under 11 | $461 |
Brand drugs: 430 claims; generic drugs: 2,087 claims; opioid claims: 295.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Horng-Chyi R Lai $95K ($95K in general payments such as food, travel and fees) from 16 companies. The largest payer was Amgen Inc. with $63K.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 86 | $63K |
| Mallinckrodt Hospital Products Inc. | 10 | $11K |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $7,187 |
| E.R. Squibb & Sons, L.L.C. BMY | 9 | $6,941 |
| Abbvie Inc. ABBV | 13 | $5,848 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $263 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $235 |
| UCB, Inc. UCB.BR | 6 | $166 |
| ANI Pharmaceuticals, Inc. ANIP | 3 | $164 |
| Actelion Pharmaceuticals US, Inc. JNJ | 1 | $66.24 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.